Local leading drugmakers at crossroad

Prospects have been grim for Korean pharmaceutical companies, as they are getting pressed by multinationals' increasing market presence and the government's pressure to lower drug costs, such as a cash incentive plan for hospitals and pharmacies, which will take effect in October.

Side effects are discovered in some university hospitals, threatening to choose to prescribe originals over gene...